Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis
2022 Ceriani, L; Milan, L; Cascione, L; Gritti, G; Dalmasso, F; Esposito, F; Pirosa, M; Schar, S; Bruno, A; Dirnhofer, S; Giovanella, L; Hayoz, S; Mamot, C; Rambaldi, A; Chauvie, S; Zucca, E
Spleen tyrosine kinase/FMS-Like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/ CB-659
2023 Gordon, L; Karmali, R; Kaplan, J; Popat, R; Burris, H; Ferrari, S; Madan, S; Patel, M; Gritti, G; El-Sharkawi, D; Chau, F; Radford, J; de Oteyza, J; Zinzani, P; Iyer, S; Townsend, W; Miao, H; Proscurshim, I; Wang, S; Katyayan, S; Yuan, Y; Zhu, J; Stumpo, K; Shou, Y; Carpio, C; Bosch, F
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
2024 Zinzani, P; Izutsu, K; Mehta-Shah, N; Barta, S; Ishitsuka, K; Cordoba, R; Kusumoto, S; Bachy, E; Cwynarski, K; Gritti, G; Prica, A; Jacobsen, E; Feldman, T; Guillermin, Y; Ennishi, D; Yoon, D; Domenech, E; Zain, J; Wang, J; Kim, J; Poel, M; Jin, J; Wu, S; Chen, Y; Moriyama, T; Inoue, A; Nakajima, K; Horwitz, S
Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure
2021 Damiani, M; Gandini, L; Landi, F; Borleri, G; Fabretti, F; Gritti, G; Riva, I
Immunotherapy of acute lymphoblastic leukemia and lymphoma with T cell–redirected bispecific antibodies
2021 Lussana, F; Gritti, G; Rambaldi, A
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma
2024 Pinto, A; Caltagirone, M; Battista, M; Gazzoli, G; Patti, C; Pennese, E; Delorenzo, S; Pavone, V; Merli, M; Chiarenza, A; Gorgone, A; Piazza, F; Puccini, B; Noto, A; Arcaini, L; Defilippi, R; Zinzani, P; Ferreri, A; Ladetto, M; Ferrari, S; Gritti, G
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
2021 Brunetta, E; Folci, M; Bottazzi, B; De Santis, M; Gritti, G; Protti, A; Mapelli, S; Bonovas, S; Piovani, D; Leone, R; My, I; Zanon, V; Spata, G; Bacci, M; Supino, D; Carnevale, S; Sironi, M; Davoudian, S; Peano, C; Landi, F; Di Marco, F; Raimondi, F; Gianatti, A; Angelini, C; Rambaldi, A; Garlanda, C; Ciccarelli, M; Cecconi, M; Mantovani, A
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
2024 Yuen, S; Phillips, T; Bannerji, R; Marlton, P; Gritti, G; Seymour, J; Johnston, A; Arthur, C; Dodero, A; Sharma, S; Hirata, J; Musick, L; Flowers, C
Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma
2024 Gritti, G; Belousov, A; Relf, J; Dixon, M; Tandon, M; Komanduri, K
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL
2024 Gritti, G; Ferrari, S; Lussana, F; Barbui, A; Landi, F; Rondi, M; Putelli, A; Ballardini, F; Quaresmini, G; Paganessi, M; Pavoni, C; Ghirardi, A; Gotti, E; Capelli, C; Golay, J; Introna, M; Rambaldi, A
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences
2024 Violetti, S; Ardigo, M; Fava, P; Gritti, G; Morsia, E; Onida, F; Paulli, M; Pileri, A; Quaglino, P; Rupoli, S; Teoli, M; Vezzoli, P
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
2023 Bachy, E; Savage, K; Huang, H; Kwong, Y; Gritti, G; Zhang, Q; Liberati, A; Cao, J; Yang, H; Hao, S; Hu, J; Zhou, K; Petrini, M; Russo, F; Zhang, H; Sang, W; Ji, J; Ferreri, A; Damaj, G; Liu, H; Zhang, W; Ke, X; Ghiggi, C; Huang, S; Li, X; Yao, H; Paik, J; Novotny, W; Zhou, W; Zhu, H; Zinzani, P
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up
2023 Zinzani, P; Santoro, A; Gritti, G; Brice, P; Barr, P; Kuruvilla, J; Cunningham, D; Kline, J; Johnson, N; Mehta-Shah, N; Lisano, J; Wen, R; Akyol, A; Moskowitz, A
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
2022 Garcia-Sancho, A; Bellei, M; Lopez-Parra, M; Gritti, G; Cortes, M; Novelli, S; Panizo, C; Petrucci, L; Gutierrez, A; Dlouhy, I; Bastos-Oreiro, M; Sancho, J; Ramirez, M; Moraleda, J; Carrillo, E; Jimenez-Ubieto, A; Jarque, I; Orsucci, L; Garcia-Torres, E; Montalban, C; Dodero, A; Arranz, R; de las Heras, N; Pascual, M; Lopez-Jimenez, J; Spina, M; Re, A; de Villambrosia, S; Bobillo, S; Federico, M; Caballero, D
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
2021 Armand, P; Janssens, A; Gritti, G; Radford, J; Timmerman, J; Pinto, A; Mercadal Vilchez, S; Johnson, P; Cunningham, D; Leonard, J; Rodig, S; Martin-Regueira, P; Sumbul, A; Samakoglu, S; Tang, H; Ansell, S
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma A C
2020 Gordon, L; Kaplan, J; Popat, R; Burris, H; Ferrari, S; Madan, S; Patel, M; Gritti, G; El-Sharkawi, D; Chau, I; Radford, J; de Oteyza, J; Zinzani, P; Iyer, S; Townsend, W; Karmali, R; Miao, H; Proscurshim, I; Wang, S; Wu, Y; Stumpo, K; Shou, Y; Carpio, C; Bosch, F
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- And T-cell lymphoma models
2020 Tarantelli, C; Lange, M; Gaudio, E; Cascione, L; Spriano, F; Kwee, I; Arribas, A; Rinaldi, A; Jourdan, T; Berthold, M; Sturz, A; Sperl, C; Margheriti, F; Scalise, L; Gritti, G; Rossi, D; Stathis, A; Liu, N; Zucca, E; Politz, O; Bertoni, F
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma
2020 Zinzani, P; Flinn, I; Yuen, S; Topp, M; Rusconi, C; Fleury, I; Le Du, K; Arthur, C; Pro, B; Gritti, G; Crump, M; Petrich, A; Samineni, D; Sinha, A; Punnoose, E; Szafer-Glusman, E; Spielewoy, N; Mobasher, M; Humphrey, K; Kornacker, M; Hiddemann, W
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
2020 Gonzalez-Barca, E; Boumendil, A; Blaise, D; Trneny, M; Masszi, T; Finel, H; Michieli, M; Bittenbring, J; Gritti, G; Snowden, J; Bishton, M; Bruno, B; de Villambrosia, S; Janikova, A; Leleu, X; Anagnostopoulos, A; Poire, X; Crysandt, M; Ozkurt, Z; Vandenberghe, E; Itala-Remes, M; Cahn, J; Jantunen, E; Schroyens, W; Maertens, J; Esquirol, A; Dreger, P; Montoto, S; Sureda, A
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma
2020 Viardot, A; Hess, G; Bargou, R; Morley, N; Gritti, G; Goebeler, M; Iskander, K; Cohan, D; Zhang, A; Franklin, J; Coyle, L
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Keyword
- Humans5390
- Female2987
- Male2635
- Middle Aged1894
- Adult1799
- Aged1494
- Italy1198
- COVID-191166
- Animals1034
- Nuclear and High Energy Physics742
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS1338
- PHYSICAL REVIEW LETTERS915
- JOURNAL OF HYPERTENSION793
- PHYSICS LETTERS. SECTION B699
- PHYSICAL REVIEW D572
- THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS529
- SCIENTIFIC REPORTS508
- MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY489
- ASTRONOMY & ASTROPHYSICS462
- PLOS ONE461
Editore
- Springer2402
- Elsevier B.V.2252
- Elsevier2219
- Oxford University Press2208
- Elsevier Ltd2202
- American Physical Society2028
- MDPI1969
- Elsevier BV1735
- Elsevier Inc.1303
- Lippincott Williams and Wilkins1264
Lingua
- eng72513
- ita15363
- fre375
- spa236
- por85
- ger53
- ara23
- rus14
- arc8
- chi8
Settore disciplinare
- MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE62
- M-PED/01 - PEDAGOGIA GENERALE E SOCIALE45
- M-PSI/08 - PSICOLOGIA CLINICA39
- INF/01 - INFORMATICA34
- FIS/05 - ASTRONOMIA E ASTROFISICA33
- GEO/08 - GEOCHIMICA E VULCANOLOGIA27
- ING-INF/05 - SISTEMI DI ELABORAZIONE DELLE INFORMAZIONI26
- IUS/08 - DIRITTO COSTITUZIONALE26
- CHIM/03 - CHIMICA GENERALE ED INORGANICA25
- IUS/01 - DIRITTO PRIVATO25
Tipologia
- 01 - Articolo su rivista88408
- 99 - Altro3
- 03 - Contributo in libro2
- 02 - Intervento a convegno1
Accesso al fulltext
- no fulltext49514
- open22592
- reserved14633
- partially open1603
- embargoed62
- mixed9
Progetto
- -1042
- DIP-ECC-DISAT-2018242
- DIP-ECC-MATER-2018152
- MUSA43
- DIP-ECC-FORMAZIONE-2334
- DIP-ECC-PSICOLOGIA-202323
- SWAB22
- UNIMIB-ARIA Toolkit20
- UNICORN19
- ICSC18